ArticleCureus2024

First Use of Upfront Polatuzumab Vedotin in Post-transplant Lymphoproliferative Disorder: A Case Report.

Sreshta Paranji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.